Cape Investment Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Buy
5,074
+651
+15% +$52.5K 0.11% 148
2026
Q1
$383K Buy
4,423
+296
+7% +$28.4K 0.13% 144
2025
Q4
$396K Buy
4,127
+460
+13% +$44.7K 0.12% 134
2025
Q3
$349K Buy
3,667
+62
+2% +$5.7K 0.34% 75
2025
Q2
$314K Buy
3,605
+113
+3% +$9.58K 0.11% 140
2025
Q1
$314K Sell
3,492
-36
-1% -$3.22K 0.13% 129
2024
Q4
$282K Buy
3,528
+286
+9% +$24.8K 0.11% 140
2024
Q3
$292K Buy
3,242
+249
+8% +$20.9K 0.12% 127
2024
Q2
$236K Sell
2,993
-245
-8% -$20.1K 0.11% 135
2024
Q1
$282K Buy
3,238
+41
+1% +$3.5K 0.13% 117
2023
Q4
$263K Buy
3,197
+369
+13% +$28.1K 0.13% 115
2023
Q3
$222K Buy
2,828
+574
+25% +$48.1K 0.13% 121
2023
Q2
$199K Buy
2,254
+86
+4% +$7.4K 0.11% 135
2023
Q1
$175K Buy
+2,168
New +$177K 0.11% 136

Other funds holding MDT

Cape Investment Advisory's MDT Position: Q2 2026 in Review

Cape Investment Advisory increased its Medtronic (MDT) stake by 15% in Q2 2026, buying an estimated $52.5K and bringing the position to 5,074 shares worth $397K. The position accounts for 0.11% of the portfolio, ranked #148.

Cape Investment Advisory first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cape Investment Advisory held 5,074 shares of Medtronic worth $397K as of Q2 2026.
  • Cape Investment Advisory bought 651 Medtronic shares in Q2 2026, an estimated $52.5K.
  • Medtronic made up 0.11% of Cape Investment Advisory's portfolio in Q2 2026, its #148 holding.
  • Cape Investment Advisory first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.